REVVITY, INC Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
REVVITY, INC (RVTY) had Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net of $0 as of 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet · last filed 2018-02-27
- 2017-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $0.00.
- 2017-10-01: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $0.00.
- 2017-07-02: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $0.00.
- 2017-04-02: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $23.79M.
| Period end | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2017-10-01 | $0.00 10-Q · filed 2017-11-07 |
| 2017-07-02 | $0.00 10-Q · filed 2017-08-08 |
| 2017-04-02 | $23.79M 10-Q · filed 2017-05-09 |
| 2017-01-01 | $28.40M 10-K · filed 2018-02-27 |
| 2016-01-03 | $23.95M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |